Fmr LLC Vaxcyte, Inc. Transaction History

Fmr LLC

$1.49 Trillion
Q1 2025

A detailed history of Fmr LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Fmr LLC holds 12,512,234 shares of PCVX stock, worth $438 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

12,512,234

Previous 13,091,648 4.43%

Holding current value

$438 Million

Previous $1.07 Billion 55.91%

% of portfolio

0.03%

Previous 0.07%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$37.76 - $92.13 $21.9 Million - $53.4 Million	-579,414 Reduced 4.43%	12,512,234 $472 Million
Q4 2024 Feb 13, 2025	SELL	$80.97 - $117.93 $219 Million - $319 Million	-2,709,019 Reduced 17.14%	13,091,648 $1.07 Billion
Q3 2024 Nov 13, 2024	SELL	$70.52 - $117.12 $25.9 Million - $42.9 Million	-366,673 Reduced 2.27%	15,800,667 $1.8 Billion
Q2 2024 Aug 13, 2024	SELL	$60.06 - $78.77 $5.63 Million - $7.39 Million	-93,819 Reduced 0.58%	16,167,340 $1.22 Billion
Q1 2024 May 13, 2024	BUY	$59.79 - $81.05 $122 Million - $166 Million	2,047,794 Added 14.41%	16,261,159 $1.11 Billion
Q4 2023 Feb 13, 2024	BUY	$45.35 - $63.41 $6.18 Million - $8.64 Million	136,328 Added 0.97%	14,213,365 $893 Million
Q3 2023 Nov 13, 2023	BUY	$46.0 - $53.1 $956,846 - $1.1 Million	20,801 Added 0.15%	14,077,037 $718 Million
Q2 2023 Aug 11, 2023	BUY	$34.66 - $54.07 $77.9 Million - $122 Million	2,247,671 Added 19.03%	14,056,236 $702 Million
Q1 2023 May 11, 2023	BUY	$36.27 - $47.2 $59.5 Million - $77.4 Million	1,639,283 Added 16.12%	11,808,565 $443 Million
Q4 2022 Feb 13, 2023	BUY	$20.58 - $47.95 $26.2 Million - $61 Million	1,272,085 Added 14.3%	10,169,282 $488 Million
Q3 2022 Nov 10, 2022	BUY	$21.69 - $28.53 $8.32 Million - $10.9 Million	383,791 Added 4.51%	8,897,197 $214 Million
Q2 2022 Aug 12, 2022	BUY	$17.68 - $26.58 $2.41 Million - $3.63 Million	136,464 Added 1.63%	8,513,406 $185 Million
Q1 2022 May 13, 2022	BUY	$17.46 - $26.36 $8.78 Million - $13.2 Million	502,592 Added 6.38%	8,376,942 $202 Million
Q4 2021 Feb 14, 2022	BUY	$19.32 - $26.45 $888,043 - $1.22 Million	45,965 Added 0.59%	7,874,350 $187 Million
Q3 2021 Nov 15, 2021	BUY	$20.26 - $26.97 $2.46 Million - $3.28 Million	121,576 Added 1.58%	7,828,385 $199 Million
Q2 2021 Aug 13, 2021	BUY	$16.45 - $24.06 $127 Million - $185 Million	7,706,809 New	7,706,809 $173 Million

Others Institutions Holding PCVX

# of Institutions

345

Shares Held

136M

Call Options Held

348K

Put Options Held

250K

View Full List

About Vaxcyte, Inc.

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $2.08B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

More about PCVX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account